Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Future Microbiology
|
January 11, 2020
Ceftobiprole versus daptomycin in <i>Staphylococcus aureus</i> bacteremia: a novel protocol for a double-blind, Phase III trial
Kamal Hamed, Marc Engelhardt, Mark E Jones, et al.
Plos One
|
June 24, 2025
Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance
Andrew F Shorr, Mark E Jones, Silke Friedmann, et al.
Antimicrobial Agents and Chemotherapy
|
March 15, 2017
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole
Laura L Kovanda, Francisco M Marty, Johan Maertens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 20, 2017
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
Andreas H Groll, Robert Townsend, Amit Desai, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
October 3, 2006
Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. An echocardiographic multicenter comparison study using myocardial contrast echocardiography and 2D echocardiography
Rainer Hoffmann, Adrian C Borges, Jaroslaw D Kasprzak, et al.
The Journal of Antimicrobial Chemotherapy
|
March 28, 2025
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials
Thomas L Holland, Andrew F Shorr, J Scott Overcash, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2026
Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults
Keith A Rodvold, Mark H Gotfried, Carlos Fernando de Oliveira, et al.
American Journal of Cancer Research
|
June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models
Filippo Spriano, Luca Aresu, Luciano Cascione, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Dimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Investigational New Drugs
|
February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study
Markus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Future Microbiology
|
January 11, 2020
Ceftobiprole versus daptomycin in <i>Staphylococcus aureus</i> bacteremia: a novel protocol for a double-blind, Phase III trial
Kamal Hamed, Marc Engelhardt, Mark E Jones, et al.
Plos One
|
June 24, 2025
Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance
Andrew F Shorr, Mark E Jones, Silke Friedmann, et al.
Antimicrobial Agents and Chemotherapy
|
March 15, 2017
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole
Laura L Kovanda, Francisco M Marty, Johan Maertens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 20, 2017
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
Andreas H Groll, Robert Townsend, Amit Desai, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
October 3, 2006
Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. An echocardiographic multicenter comparison study using myocardial contrast echocardiography and 2D echocardiography
Rainer Hoffmann, Adrian C Borges, Jaroslaw D Kasprzak, et al.
The Journal of Antimicrobial Chemotherapy
|
March 28, 2025
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials
Thomas L Holland, Andrew F Shorr, J Scott Overcash, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2026
Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults
Keith A Rodvold, Mark H Gotfried, Carlos Fernando de Oliveira, et al.
American Journal of Cancer Research
|
June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models
Filippo Spriano, Luca Aresu, Luciano Cascione, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Dimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Investigational New Drugs
|
February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study
Markus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
Page
of 5